IRMD · NASDAQ
IRadimed Corporation
$78.30 -7.52 (-8.76%)
Company overview
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers the MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets, and an MRI compatible patient vital signs monitoring system. The company also provides non-magnetic IV poles, wireless remote displays and controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical support representatives, and independent distributors.
- Sector
- Healthcare
- Industry
- Medical - Devices
- Exchange
- NASDAQ
- Market cap
- $1B
- Employees
- 160
- Headquarters
- Winter Springs, FL
- Website
- iradimed.com
- CEO
- Roger E. Susi
- Listed
- July 16, 2014
- P/E
- 43.01
- Dividend yield
- 1.46%
Company financials
- Revenue
- $86.3M
- Gross profit
- $66.3M
- Operating income
- $28M
- EBITDA
- $30.5M
- Net income
- $23.6M
- EPS
- $1.86
- Total assets
- $114M
- Total debt
- $0.00
- Gross margin
- 76.84%
- Net margin
- 27.36%
- Earnings yield
- 2.33%
Showing FY 2025
IRMD
1D
NASDAQ
O85.48H86.84L85.48C85.82+1.89 (+2.25%)Vol16.30K